Ganglioside-mediated aggregation of amyloid β-proteins (Aβ): Comparison between Aβ-(1-42) and Aβ-(1-40)

Journal of Neurochemistry

Volumn 116, Issue 5, 2011, Pages 851-857

  Ogawa, Mariko ^a   Tsukuda, Miho ^a   Yamaguchi, Takahiro ^a   Ikeda, Keisuke ^a   Okada, Takuma ^a   Yano, Yoshiaki ^a   Hoshino, Masaru ^a   Matsuzaki, Katsumi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; amyloid protein; cytotoxicity; gangliosides; oligomer

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GANGLIOSIDE; LIPOSOME; OLIGOMER;

ALPHA HELIX; AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CELL DEATH; CELL MEMBRANE; CELL STRUCTURE; CELL VIABILITY; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LIPID RAFT; NEUROFILAMENT; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN LIPID INTERACTION; PROTEIN SECONDARY STRUCTURE;

AMYLOID; AMYLOID BETA-PEPTIDES; CELL DEATH; CELL LINE, TUMOR; CELL MEMBRANE; GANGLIOSIDES; HUMANS; LIPOSOMES; MEMBRANE MICRODOMAINS; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PROTEIN BINDING; TIME FACTORS;

EID: 79851481547     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06997.x     Document Type: Article

References (34)

1. Ariga T., McDonald M. P., and, Yu R. K., (2008) Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease-a review. J. Lipid Res. 49, 1157-1175.
2. Ban T., Hamada D., Hasegawa K., Naiki H., and, Goto Y., (2003) Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J. Biol. Chem. 278, 16462-16465. (Pubitemid 36799502)
3. 1-42 oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95, 834-847. (Pubitemid 41567174)
4. Bateman D. A., and, Chakrabartty A., (2009) Two distinct conformations of Aβ aggregates on the surface of living PC12 cells. Biophys. J. 96, 4260-4267.
5. 1-42 into globular neurotoxins. Biochemistry 42, 12749-12760.
6. Dahlgren K. N., Manelli A. M., Stine Jr. W. B., Baker L. K., Krafft G. A., and, LaDu M. J., (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053. (Pubitemid 34969015)
7. Demuro A., Mina E., Kayed R., Milton S. C., Parker I., and, Glabe C. G., (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280, 17294-17300. (Pubitemid 41389198)
8. Deshpande A., Mina E., Glabe C., and, Busciglio J., (2006) Different conformations of β amyloid induce neurotoxicity by distinct mechasnism in human cortical neurons. J. Neurosci. 26, 6011-6018. (Pubitemid 44318367)
9. Engel M. F., Khemtémourian L., Kleijer C. C., Meeldijk H. J., Jacobs J., Verkleij A. J., de Kruijff B., Killian J. A., and, Höppener J. W., (2008) Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc. Natl Acad. Sci. USA 105, 6033-6038. (Pubitemid 351758394)
10. Grace E. A., Rabiner C. A., and, Busciglio J., (2002) Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer's disease. Neuroscience 114, 265-273. (Pubitemid 35247506)
11. Hardy J., and, Selkoe D. J., (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
12. Hayashi H., Kimura N., Yamaguchi H., et al. (2004) A seed for Alzheimer amyloid in the brain. J. Neurosci. 24, 4894-4902. (Pubitemid 38668215)
13. Hoshi M., Sato M., Matsumoto S., Nogichi A., Yasutake K., Yoshida N., and, Sato K., (2003) Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β. Proc. Natl Acad. Sci. USA 100, 6370-6375. (Pubitemid 36666588)
14. Ikeda K., and, Matsuzaki K., (2008) Driving force of binding of amyloid β-protein to lipid bilayers. Biochem. Biophys. Res. Commun. 370, 525-529.
15. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and, Ihara Y., (1994) Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ 42(43). Neuron 13, 45-53.
16. Jana A., and, Pahan K., (2004) Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J. Biol. Chem. 279, 51451-51459. (Pubitemid 40017893)
17. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y., and, Matsuzaki K., (2001) Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276, 24985-24990.
18. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y., and, Matsuzaki K., (2002) Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41, 7385-7390. (Pubitemid 34602456)
19. Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W., and, Glabe C. G., (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. (Pubitemid 36444329)
20. Knowles T. P., Waudby C. A., Devlin G. L., Cohen S. I., Aguzzi A., Vendruscolo M., Terentjev E. M., Welland M. E., and, Dobson C. M., (2009) An analytical solution to the kinetics of breakable filament assembly. Science 326, 1533-1537.
21. 1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448-6453.
22. Lesné S., Koh M. T., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gallagher M., and, Ashe K. H., (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357.
23. Matsuzaki K., (2007) Physicochemical interactions of amyloid β-peptide with lipid bilayers. Biochim. Biophys. Acta 1768, 1935-1942. (Pubitemid 47135568)
24. Matsuzaki K., and, Horikiri C., (1999) Interactions of amyloid β-peptide (1-40) with ganglioside-containing membranes. Biochemistry 38, 4137-4142.
25. Matsuzaki K., Noguch T., Wakabayashi M., Ikeda K., Okada T., Ohashi Y., Hoshino M., and, Naiki H., (2007) Inhibitors of amyloid β-protein aggregation mediated by GM1-containing raft-like membranes. Biochim. Biophys. Acta 1768, 122-130. (Pubitemid 44909079)
26. Matsuzaki K., Kato K., and, Yanagisawa K., (2010) Aβ polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta 1801, 868-877.
27. Mattson M. P., (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639. (Pubitemid 39061671)
28. Noguchi A., Matsumura S., Dezawa M., et al. (2009) Isolation and characterization of patient-derived, toxic, high mass amyloid β-protein (Aβ) assembly from Alzheimer disease brains. J. Biol. Chem. 284, 32859-32905.
29. Okada T., Ikeda K., Wakabayashi M., Ogawa M., and, Matsuzaki K., (2008) Formation of toxic Aβ(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Aβ (1-40) fibrils. J. Mol. Biol. 382, 1066-1074.
30. Tsai J., Grutzendler J., Duff K., and, Gan W.-B., (2004) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7, 1181-1183. (Pubitemid 39426234)
31. Wakabayashi M., and, Matsuzaki K., (2007) Formation of amyloids by Aβ-(1-42) on NGF-differentiated PC12 cells: roles of gangliosides and cholesterol. J. Mol. Biol. 371, 924-933. (Pubitemid 47101820)
32. Wakabayashi M., Okada T., Kozutsumi Y., and, Matsuzaki K., (2005) GM1 ganglioside-mediated accumulation of amyloid β-protein on cell membranes. Biochem. Biophys. Res. Commun. 328, 1019-1023. (Pubitemid 40238737)
33. Walsh D. M., Kyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J., and, Selkoe D. J., (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. (Pubitemid 34288854)
34. Yanagisawa K., Odaka A., Suzuki N., and, Ihara Y., (1995) GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1, 1062-1066.